Initial experience of a geriatric oncology clinic in a tertiary cancer center in India

• DOI: 10.4103/crst.crst_119_20
• Publication Date: 2020-07-14T23:24:40Z
• Authors: Kumar Prabhash; Vanita Noronha; Anant Ramaswamy; Ratan Dhekle; Vikas Talreja; Vikram Gota; Kalpita Gawit; Manjunath Krishna...; VijayMaruti Patil; Amit Joshi; Nandini Menon; Akhil Kapoor; Anbarasan Sekar; Darshit Shah; Vikas Ostwal; Shripad Banavali
• Keywords: Geriatric oncology; Interquartile range; Neurocognitive

Background: Little is known about the comprehensive geriatric assessment (CGA) profile of Indian patients. We aimed to describe CGA results oncology patients and identify incidence polypharmacy. Methods: The study a retrospective analysis data collected in clinic at Tata Memorial Hospital, tertiary cancer hospital India. Patients aged 60 years over with malignancy were evaluated. baseline social, demographic, disease details recorded. All underwent CGA, which domains nutrition, function falls, psychological status, cognition, comorbidities, social support, fatigue, polypharmacy evaluated using various validated tools. Life expectancy risk toxicity from chemotherapy calculated. Based on referred specialists advised methods address any identified vulnerabilities. was approved by Institutional Review Board, granted waiver requirement for written informed consent. Results: A total 251 assessed between June 2018 March 2020. had solid tumor malignancies, commonly lung (41%) gastrointestinal (28%). Fifty-nine percent planned palliative intent therapy. median age 70 (range, 60–100). number caregivers 4 (interquartile range [IQR], 3–6). body mass index (BMI) 21.9 kg/m2 (IQR, 18.9–24.2). BMI 109 (44%) 51% developing Grade 3 or higher if treated full-dose combination chemotherapy. Conclusion: Ninety-eight vulnerabilities least one domain. Polypharmacy noted more than 50% There an predicted severe two out every three